Drug Type TCR therapy |
Synonyms |
Target |
Mechanism KRAS G13D inhibitors(KRAS G13D inhibitors), Gene transference, T lymphocyte replacements |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | CN | 13 Feb 2023 |